Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics

2 Aug 2022

Abstract excerpt

Due to fast transmission and various circulating SARS-CoV-2 variants, a significant increase of coronavirus 2019 infection cases with acute respiratory symptoms has prompted worries about the efficiency of current vaccines. The possible evasion from vaccine immunity urged scientists to identify novel therapeutic targets for developing improved vaccines to manage worldwide COVID-19 infections. Our study sequenced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35983322
DOI: 10.3389/fmicb.2022.901848

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based NanotherapeuticsPMID 35983322Read ↗

Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infectionSemantic proximity Read ↗

Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanismSemantic proximity Read ↗

SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic InterventionsSemantic proximity Read ↗

SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic InterventionsSemantic proximity Read ↗

Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic InterventionsSemantic proximity Read ↗

COVID-19: A state of art on immunological responses, mutations, and treatment modalities in riposte.Semantic proximity Read ↗

Delineating COVID-19 immunological features using single-cell RNA sequencingSemantic proximity Read ↗

Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cellsSemantic proximity Read ↗

SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeuticsSemantic proximity Read ↗

Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic dataSemantic proximity Read ↗

Bioinformatics analysis of single-cell mRNA-seq of SARS-CoV-1 and SARS-CoV-2 infection compared to MERS-CoV from Sequence Read Archive (SRA) database reveals novel targets for therapiesSemantic proximity Read ↗

Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.